Medication info
Twinact Tablet 40/10 Milligrams

Twinact Tablet 40/10 Milligrams

Prescription medicationOral
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Dasan Pharmaceutical Co., Ltd.
Appearance
A white and light gray biconvex oval double tablet.
Packaging
30 tablets (10 tablets/PTP X 3)
Approval status
Active

MFDS item code 201605706 · Approved 2016.09.29 · Insurance code 678600690

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this drug; however, a direct switch to this drug may be considered if blood pressure is not controlled with the individual components as follows. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment; however, it is recommended that treatment be initiated at a low dose in patients with severe renal impairment, with gradual dose increases. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage is recommended for older adults, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring caution in administration’.) In older adults aged 75 years and older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
Child dose
○ Children: Administration of this drug is not recommended in pediatric patients aged 18 years or younger because safety and efficacy have not been established.

Ingredients

Manufacturer
Dasan Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential Hypertension
View approved original text

For patients with essential hypertension, if blood pressure is not sufficiently controlled with monotherapy of Amlodipine or Telmisartan, this medication can effectively control blood pressure. It helps lower blood pressure steadily, thereby reducing the risk of cardiovascular complications. Therefore, it is recommended as a suitable treatment option for patients with hypertension who have difficulty managing their blood pressure.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this drug; however, a direct switch to this drug may be considered if blood pressure is not controlled with the individual components as follows. - 40/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this drug 40/5 milligrams. - 40/10 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment; however, it is recommended that treatment be initiated at a low dose in patients with severe renal impairment, with gradual dose increases. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage is recommended for older adults, but caution should be exercised when increasing the dose. (See section ‘3. Patients requiring caution in administration’.) In older adults aged 75 years and older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.

Child dose

○ Children: Administration of this drug is not recommended in pediatric patients aged 18 years or younger because safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should not be used by pregnant women or women who may become pregnant. It should not be administered to individuals with allergies to the active substance or similar components, those with severely impaired liver or heart function, severe hypotension patients, or unstable patients following acute myocardial infarction. Patients with specific conditions, such as primary aldosteronism, heart valve disease, liver disorders, gastrointestinal diseases, renal issues, and the elderly, should use this medication cautiously and follow their doctor’s instructions strictly. During treatment with this medication, side effects such as dizziness and peripheral edema may frequently occur, and serious side effects have been reported rarely. If any unusual symptoms appear, immediate consultation with healthcare professionals is necessary. This medication should not be taken during pregnancy, and if pregnancy is confirmed, it should be discontinued immediately and replaced with other safe treatments. It can lower blood pressure suddenly, so patients at high risk of hypotension should manage their condition well before taking this medication, and if hypotensive symptoms appear, they should seek appropriate measures. There is a risk of elevated blood potassium levels, so caution is needed when used with potassium supplements or potassium-containing foods, and regular blood tests are recommended. Patients with impaired renal function should frequently monitor their kidney function while taking this medication, and there is insufficient experience with transplant patients. Patients with heart disease need to be cautious as the risk of angina or myocardial infarction may increase when taking this medication. This medication may cause drowsiness or dizziness, so caution is required when driving or operating hazardous machinery. It may interact with other medications, so especially when taken with lithium, digoxin, warfarin, and non-steroidal anti-inflammatory drugs, consultation with a doctor or pharmacist is necessary. This medication contains sorbitol, so it should be avoided by patients with fructose intolerance. In cases of overdose, symptoms such as hypotension, arrhythmias, and acute kidney failure may occur, requiring immediate medical treatment. It is not recommended for children as safety and efficacy have not been established in pediatric patients under 18 years of age. Elderly patients may react more sensitively to this medication, so it should be started at a low dose and gradually increased.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 101 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • mood changes
  • anxiety
  • confusional state
  • drowsiness
  • headache
  • migraine
  • sensory disturbances
  • sensory loss
  • taste disorders
  • tremors
  • extrapyramidal disorder
  • muscle tone increase
  • visual disturbances
  • diplopia
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • changes in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • liver function abnormalities
  • liver disorders
  • hepatitis
  • jaundice
  • increased liver enzymes
  • itching
  • hyperhidrosis
  • rash
  • hair loss
  • purpura
  • skin discoloration
  • eczema
  • erythema
  • angioedema
  • toxic skin rash
  • drug rash
  • urticaria
  • erythema multiforme
  • exfoliative dermatitis
  • Stevens-Johnson syndrome
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • polyuria
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • asthenia
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that does not allow light in. Additionally, it is important to keep it at a temperature between 1°C and 30°C to maintain its effectiveness.

Appearance and packaging

Appearance

A white and light gray biconvex oval double tablet.

Package unit

30 tablets (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.